Posttreatment exacerbation of hepatitis B virus (HBV) infection in long-term HBV trials of emtricitabine

被引：19
|
作者：
Mondou, E [1 ]
Sorbel, J [1 ]
Anderson, J [1 ]
Mommeja-Marin, H [1 ]
Rigney, A [1 ]
Rousseau, F [1 ]
机构：
[1] Gilead Sci Inc, Durham, NC 27707 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2005年 / 41卷 / 05期
关键词：
D O I：
10.1086/432581
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Posttreatment exacerbation of hepatitis B virus (HBV) infection in long-term HBV trials of emtricitabine occurred in 23% of patients. Development of antibody to hepatitis e antigen did not prevent hepatic flare. One patient with marked bridging fibrosis required liver transplantation. Patients with advanced liver disease are at risk for hepatic flare with decompensation if active treatment is withdrawn (e.g., when highly active antiretroviral treatment is modified).
引用
收藏
页码：E45 / E47
页数：3
相关论文
共 50 条
  • [1] EFFICACY OF HEPATITIS-B VIRUS (HBV) VACCINE IN LONG-TERM PREVENTION OF HBV INFECTION
    PONGPIPAT, D
    SUVATTE, V
    ASSATTEERAWATS, A
    [J]. ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 1988, 6 (01): : 19 - 22
  • [2] Long-Term Outcome of Hepatitis B and Hepatitis C Virus Co-Infection and Single HBV Infection Acquired in Youth
    Zampino, Rosa
    Marrone, Aldo
    Merola, Antonietta
    Trani, Barbara
    Cirillo, Grazia
    Karayiannis, Peter
    Coppola, Nicola
    Zappala, Rosario
    Utili, Riccardo
    Ruggiero, Giuseppe
    Adinolfi, Luigi E.
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (12) : 2012 - 2020
  • [3] The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy
    Nicola Coppola
    Anna Rita Corvino
    Stefania De Pascalis
    Giuseppe Signoriello
    Eliana Di Fiore
    Albert Nienhaus
    Evangelista Sagnelli
    Monica Lamberti
    [J]. BMC Infectious Diseases, 15
  • [4] The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy
    Coppola, Nicola
    Corvino, Anna Rita
    De Pascalis, Stefania
    Signoriello, Giuseppe
    Di Fiore, Eliana
    Nienhaus, Albert
    Sagnelli, Evangelista
    Lamberti, Monica
    [J]. BMC INFECTIOUS DISEASES, 2015, 15
  • [5] Hepatitis B virus (HBV) mutations during long-term therapy in chronic hepatitis B patients
    Arrese, E.
    Basaras, M.
    Blanco, S.
    Ruiz, P.
    Cisterna, R.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E233 - E234
  • [6] HEPATITIS-B VIRUS (HBV) DNA AS A MARKER OF HBV INFECTION
    NAKAJIMA, E
    THIERS, V
    LARZUL, D
    TIOLLAIS, P
    BRECHOT, C
    [J]. LIVER CELL CARCINOMA, 1989, 51 : 107 - 111
  • [7] Congenital Hepatitis B Virus (HBV) Infection
    Dalgic, Nazan
    [J]. JOURNAL OF PEDIATRIC INFECTION, 2007, 1 (02): : 63 - 67
  • [8] GENDER DIFFERENCES ON LONG-TERM OUTCOMES IN PATIENTS WITH DUAL CHRONIC HEPATITIS B VIRUS (HBV) AND CHRONIC HEPATITIS C VIRUS (HCV) INFECTION
    Shah, Sonia
    Nguyen, Pauline
    Le, An K.
    Zhao, Changqing
    Hoang, Joseph
    Yasukawa, Lee Ann
    Weber, Susan C.
    Nguyen, Mindie H.
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S1171 - S1171
  • [9] Gender differences on long-term outcomes in patients with dual chronic hepatitis B virus (HBV) and chronic hepatitis C virus (HCV) infection
    Shah, S.
    Nguyen, P.
    Le, A. K.
    Zhao, C.
    Hoang, J.
    Yasukawa, L. A.
    Weber, S. C.
    Nguyen, M. H.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S707 - S708
  • [10] Hepatitis B virus (HBV) genotyping in Belgian patients with chronic HBV infection
    Micalessi, MI
    De Cock, L
    Vranckx, R
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (06) : 499 - 501
12345